Jenna Kae Sagedahl, DPT | |
1656 Central St W, Bagley, MN 56621-4357 | |
(218) 694-6640 | |
Not Available |
Full Name | Jenna Kae Sagedahl |
---|---|
Gender | Female |
Speciality | Physical Medicine & Rehabilitation |
Location | 1656 Central St W, Bagley, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275003907 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 11304 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jenna Kae Sagedahl, DPT 1656 Central St W, Bagley, MN 56621-4357 Ph: () - | Jenna Kae Sagedahl, DPT 1656 Central St W, Bagley, MN 56621-4357 Ph: (218) 694-6640 |
News Archive
Multiple Behavior Changes In Diet And Activity - Mobile technologies have been touted for their potential benefits to health and wellness. Researchers in this study gave 204 individuals a dieting and exercise regimen. They also gave each person a handheld device to record adherence and receive remote coaching.
As scientists continue to map breast cancer's complex genetic makeup, research at Michigan State University could lead to better diagnoses and new treatment targets.
Millions of times a year, Americans get prescriptions for a week's worth of steroid pills, hoping to ease a backache or quell a nagging cough or allergy symptoms. But a new study suggests that they and their doctors might want to pay a bit more attention to the potential side effects of this medication.
A new study by researchers at NYU School of Medicine found that UVA radiation damages the DNA in human melanocyte cells, causing mutations that can lead to melanoma. Melanocytes, which contain a substance called melanin that darkens the skin to protect it from the ultraviolet rays of the sun, are more vulnerable to UVA radiation than normal skin cells because they are unable to repair themselves as efficiently.
Cambridge Heart, Inc., today announced that it has received clearance from the U.S. Food and Drug Administration to begin marketing its Microvolt T-Wave Alternans (MTWA) OEM module. The MTWA OEM module is designed to work with existing cardiac stress test platforms distributed by other manufacturers. This FDA 510(k) clearance allows Cambridge Heart to begin marketing the MTWA OEM module integrated with the Q-Stress line of stress systems manufactured by Cardiac Science Corporation, Inc..
› Verified 4 days ago